Influenza virus vaccines

Drugs of Today

Volumn 32, Issue 3, 1996, Pages 225-237

  Powers, Douglas C ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

AGE; CHILD; FEVER; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNE RESPONSE; INFLUENZA; INFLUENZA VIRUS; INTRAMUSCULAR DRUG ADMINISTRATION; MYALGIA; REVIEW; SKIN IRRITATION;

EID: 0029995896     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: None     Document Type: Review

References (102)

1. LaForce, P.M., Nichol, K.L., Cox, N.J. Influenza: Virology, epidemiology, disease, and prevention. Amer J Prev Med 1994, 10 (Suppl): 31-44.
2. Glezen, W.P. Serious morbidity and mortality associated with influenza epidemics. Epidemiol Rev 1982, 4: 25-44.
3. Kida, H., Webster, R.G., Yanagawa, R. Inhibition of virus-induced hemolysis with monoclonal antibodies to different antigenic areas on the hemagglutinin molecule of A/Seal/Massachusetts/1/80 (H7N7) influenza virus. Arch Virol 1983, 76: 91-9.
4. Yoden, S., Kida, H., Kawabara, M., Yanagawa, R., Webster, R.G. Spin labeling of influenza virus hemagglutinin permits analysis of the conformational change at low pH and its inhibition by antibody. Virus Res 1986, 4: 251-61.
5. Virelizier. J. Host defense against influenza virus: The role of anti-hemagglutinin antibody. J Immunol 1975, 115: 434-9.
6. Potter, C.W., Oxford, J.S. Determinants of immunity to influenza infection in man. Brit Med Bull 1979, 35: 69-75.
7. Jahiel, R.I., Kilbourne, E.D. Reduction in plaque size and reduction in plaque number as differing indices of influenza virus-antibody reactions. J Bacteriol 1966, 92: 1521-34.
8. Kilbourne, E.D., Laver, W.G., Schulman, J.L., Webster, R.G. Antiviral activity of antiserum specific for an influenza virus neuraminidase following influenza. I. In vitro effects. J Virol 1968, 2: 281-8.
9. Kilbourne, E.D., Palese, P., Schulman, J.L. Inhibition of viral neuraminidase as a new approach to the prevention of influenza. In: Perspectives in Virology. Pollard, M. (Ed.). Academic Press: New York 1975, 9: 99-113.
10. Murphy, B.R., Kasel, J.A., Chanock, R.M. Association of serum anti-neuraminidase antibody with resistance to influenza in man. New Engl J Med 1972, 286: 1329-32.
11. Monto, A.S., Kendal, A.P. Effect of neuraminidase antibody on Hong Kong influenza. Lancet 1973, 1: 623-5.
12. Bienenstock, J. The mucosal immunologic network. Ann Allergy 1984, 53: 535-40.
13. McGhee, J.R., Mestecky, J., Dertzbaugh, M.T., Eldridge, J.H., Hirasawa, M., Kiyono, H. The mucosal immune system. From fundamental concepts to vaccine development. Vaccine 1992, 10: 75-88.
14. Wagner, D.K., Clements, M.L., Reimer, C.R., Snyder, M., Nelson, D.L., Murphy, B.R. Analysis of immunoglobulin G antibody responses after administration of live and inactivated influenza A vaccine indicates thai nasal wash immunoglobulin G is a transudate from serum. J Clin Microbiol 1987, 25: 559-62.
15. Ada, G.L., Jones, P.D. The immune response to influenza infection. Curr Top Microbiol Immunol 1986, 128: 1-54.
16. McMichael, A. Cytotoxic Tlymphocytes specific for influenza virus. Curr Top Microbiol Immunol 1994, 189: 75-91.
17. Gotch, F., McMichael, A., Smith, G., Moss, B. Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes. J Exp Med 1987, 165: 408-16.
18. Biddison, W.E., Shaw, S., Nelson, D.L. Virus specificity of human influenza virus-immune cytotoxic T cells. J Immunol 1979, 122: 660-4.
19. Yap, K.L., Ada, G.L., McKenzie, I.F.C. Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature 1978, 273: 238-40.
20. Schulman, J.L., Kilbourne, E.D. Induction of partial specific immunity in mice by a single injection with influenza A virus. J Bacteriol 1965, 89: 170-4.
21. Rimmelzwaan, G.F., Osterhaus, A.D.M.E. Cytotoxic T lymphocyte memory: role in cross-protective immunity against influenza? Vaccine 1995, 13: 703-5.
22. McMichael, A.J., Gotch, F.M., Noble, G.R., Beare, P.A.S. Cytotoxic T-cell immunity to influenza. New Engl J Med 1983, 309: 13-7.
23. Lawson, C.M., Bennink, J.R., Restifo, N. P., Yewdell, J.W., Murphy, B.R. Primary pulmonary cytotoxic T lymphocytes induced by immunization with a vaccinia virus recombinant expressing influenza A virus nucleoprotein peptide do not protect mice against challenge. J Virol 1994, 68: 3505-11.
24. Bender, B.S., Bell, W.E., Taylor, S., Small, P.A. Jr. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes are not necessary for heterotypic immunity to influenza. J infect Dis 1994, 170: 1195-200.
25. Palladino, G., Mozdzanowska, K., Washko, G., Gerhard, W. Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice. J Virol 1995, 69: 2075-81.
26. Kilbourne, E.D. Influenza virus genetics, viral adaptation, and evolution. In: Influenza. Kilbourne, E.D. (Ed.). Plenum: New York 1987, 111-54.
27. Glezen, W.P., Keitel, W.A., Taber, L.H., Piedra, P.A., Clover, R.D., Couch, R.B. Age distribution of patients with medically-attended illnesses caused by sequential variants of influenza A/H1N1: Comparison to age-specific infection rates, 1978-1989. Amer J Epidemiol 1991, 133: 296-304.
28. National Center for Health Statistics. Current estimates from the National Health interview Survey, United States. In: Vital and Health Statistics. Public Health Service, U.S. Government Printing Office: Washington, DC, 1985, Series 10, No. 150. DHHS Publ. No. (PHS) 85-1578.
29. Barker, W.H., Mullooly, J.P. Impact of epidemic type A influenza in a defined adult population. Amer J Epidemiol 1980, 112: 798-813.
30. Fedson, D.S., Hannoun, C., Leese, J. et al. Influenza vaccination in 18 developed countries, 1980-1992. Vaccine 1995, 13: 623-7.
31. Immunization Practices Advisory Committee. Prevention and control of influenza: Part 1, vaccines. Morbid Mortal Wkly Rep 1994, 43: 1-13.
32. Palache, A.M., Beyer, W.E.P., Sprenger, M.J.W. et al. Antibody response after influenza immunization with various vaccine doses: A double-blind, placebo-controlled, multi-centre, dose-response study in nursing-home residents and young volunteers. Vaccine 1993, 11: 3-9.
33. Odelin, M.F., Pozzetto, B., Grattard, F., Benvenuto, V., Bonnevial, L. Tolerance de la vaccination grippale chez les sujets ages et le personnel soignant d'un hôpital geriatrique. Therapie 1994, 49: 447-50.
34. Margolis, K.L., Nichol, K.L., Poland, G.A., Pluhar, R.E. Frequency of adverse reactions to influenza vaccine in the elderly. A randomised, placebo-controlled trial. JAMA 1990, 264: 1139-41.
35. Govaert, T.M.E., Dinant, G.J., Aretz, K., Masurel, N., Sprenger, M.J.W., Knottnerus, J.A. Adverse reactions to influenza vaccine in elderly people: Randomised double blind placebo controlled trial. Brit Med J 1993, 307: 988-90.
36. Safranek, R.J., Lawrence, D.N., Kurland, L.T. et al. Expert Neurology Group. Reassessment of the association between Guillain-Barré Syndrome and receipt of swine influenza vaccine in 1976-1977: Results of a two-state study. Amer J Epidemiol 1991, 133: 940-51.
37. Renton, K.W., Gray, J.D., Hall, R.I. Decreased elimination of theophylline after influenza vaccination. Can Med Assoc J 1980, 123: 288-90.
38. Patriarca, P.A., Kendal, A.P., Stricof, R.L., Weber, J.A., Meissner, M.K., Dateno, B. Influenza vaccination and warfarin or theophylline toxicity in nursing home residents. New Engl J Med 1983, 308: 1601-2.
39. Gomolin, I.H., Chapeon, D.U., Luhan, P.A. Lack of effect of influenza vaccine on theophylline levels and warfarin anticoagulation in the elderly. J Amer Geriatr Soc 1985, 33: 269-72.
40. Raj, G., Kumar, R., McKinney, P. Safety of intramuscular influenza immunization among patients receiving long-term warfarin anticoagulation therapy. Arch Intern Med 1995, 155: 1529-31.
41. MacKenzie, W.R., Davis, J.P., Peterson, D.E., Hibbard, A.J., Becker, G., Zarvan, B.S. Multiple false-positive serologic tests for HIV, HTLV-1, and hepatitis C following influenza vaccination. JAMA 1992, 268: 1015-7.
42. Hobson, D., Curry, R.C., Beare, A.S., Ward-Gardner, A. Hemagglutination inhibition antibody titers as a measure of protection against influenza in man. Dev Biol Stand 1973, 20: 164-8.
43. LaMontagne, J.R., Noble, G.R., Quinnan, G.V. et al. Summary of clinical trials of inactivated influenza vaccine-1978. Rev Infect Dis 1983, 5: 723-36.
44. Cate, T.R., Couch, R.B., Parker, D., Baxter, B. Reactogenicity, immunogenicity, and antibody persistence in adults given inactivated influenza virus vaccines-1978. Rev Infect Dis 1978, 5: 737-47.
45. Kendal A.P., Noble, G.R., Dowdle, W.R. Neuraminidase content of influenza vaccines andneuraminidase antibody responses after vaccination of immunologically primed and unprimed populations. J Infect Dis 1977, 136: S415-24.
46. Kilbourne, E.D. Comparative efficacy of neuraminidase-specific and conventional influenza virus vaccines in induction of antibody to neuraminidase in humans. J Infect Dis 1976, 134: 384-94.
47. Gross, P.A., Ennis, F.A., Gaerlan, P.P., Denson, L.J., Denning, C.R., Schiffman, D. A controlled double-blind comparison of the reaciogenicity, immunogenicity, and protective efficacy of whole-virus and split-product influenza vaccines in children. J Infect Dis 1977, 136: 623-32.
48. Frank, A.L., Webster, R.G., Glezen, W.P., Cate, T. R. Immunogenicity of influenza A/USSR (H1N1) subunit vaccine in unprimed young adults. J Med Virol 1981, 7: 135-42.
49. Barry, D.W., Mayner, R.E., Staton, E. et al. Comparative trial of influenza vaccines in immunogenicity of whole virus and split product vaccines in man. Amer J Epidemiol 1976, 104: 34-46.
50. Parkman, P.D., Hopps, H.E., Rastogi, S.C., Meyer, H.M. Jr. Summary of clinical trials of influenza virus vaccines in adults. J Infect Dis 1977, 136: S722-30.
51. Quinnan, G.V., Schooley, R., Dolin, R., Ennis, F.A., Gross, P. Gwaltney, J.M. Serologic responses and systemic reactions in adults after vaccination with monovalent A/USSR/77 and trivalent A/USSR/77, A/Texas/77, B/Hong Kong/72 influenza vaccines. Rev Infect Dis 1983, 5: 748-57.
52. Powers, D.C. Increased immunogenicity of inactivated influenza virus vaccine containing purified surface antigen compared with whole virus in elderly women. Clin Diagn Lab Immunol 1994, 1: 16-20.
53. McElhaney, J.E., Meneilly, G.S., Lechelt, K.E., Beattie, B.L., Bleackley, R.C. Antibody response to whole-virus and split-virus influenza vaccines in successful ageing. Vaccine 1993, 11: 1055-60.
54. D'Alessio, D.J., Cox, P.M. Jr., Dick, E.D. Failure of inactivated influenza vaccine to protect an aged population. JAMA 1969, 210: 485-9.
55. Feery, B.J., Evered, M.G., Morrison, E. Different protection rates in various groups of volunteers given subunit influenza virus vaccine in 1976. J Infect Dis 1979, 139: 237-41.
56. Arden, N.H., Patriarca, P.A., Fasano, M.B. et al. The roles of vaccination and amantadine prophylaxis in controlling an outbreak of influenza A (H3N2) in a nursing home. Arch Intern Med 1988, 148: 865-8.
57. Cartter, M.L., Renzullo, P.O., Helgerson, S.D., Martin, S.M., Jekel, J.F. Influenza outbreaks in nursing homes: How effective is influenza vaccine in the institutionalized elderly? Infect Contr Hosp Epidemiol 1990, 11: 473-8.
58. Powers, D.C., Belshe, R.B. Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine. J Infect Dis 1993, 167: 584-92.
59. Kasel, J.A., Couch, R.B., Six, H.R., Knight, V. Antigenicity of licensed whole virion and subvirion influenza vaccines in "high risk" persons. Proc Soc Exp Biol Med 1976, 151: 742-7.
60. Phair, J., Kauffman, C.A., Bjornson, A., Adams, L., Linnemann, C. Jr. Failure to respond to influenza vaccine in the aged: Correlation with B-cell number and function. J Lab Clin Med 1978, 92: 822-8.
61. Arden, N.H., Patriarca, P.A., Kendal, A.P. Experiences in the use and efficacy of inactivated influenza vaccine in nursing homes. In: Options for the Control of Influenza. Kendal, A.P., Patriarca, P.A. (Eds.). Alan R. Liss, Inc.: New York 1986, 155-68.
62. Levine, M., Beattie, B.L., McLean, D.M., Corman, D. Characterization of the immune response to trivalent influenza vaccine in elderly men. J Amer Geriatr Soc 1987, 35: 609-15.
63. Beyer, W.E.P., Palache, A.M., Baijet, M., Masurel, N. Antibody induction by influenza vaccines in the elderly: A review of the literature. Vaccine 1989, 7: 385-94.
64. Fagiolo, U., Amadori, A., Cozzi, E. et al. Humoral and cellular immune response to influenza virus vaccination in aged humans. Aging Clin Exp Res 1993. 5: 451-8.
65. Hobson, D., Baker, F.A., Curry, R.L. Effect of influenza vaccines in stimulating antibody in volunteers with prior immunity. Lancet 1973, II: 155-6.
66. Gross, P.A., Quinnan, G.V. Jr., Weksler, M.E., Setia, U., Douglas, R.G. Jr. Relation of chronic disease and immune response to influenza vaccine in the elderly. Vaccine 1989, 7: 303-8.
67. Blumberg, E.A., Albano, C., Pruett, T. et al. The immunogenicity of influenza virus vaccine in solid organ transplant recipients. Clin Infect Dis 1996, 22: 295-302.
68. Gross, P.A., Gould, A.L., Brown, A.E. Effect of cancer chemotherapy on the immune response to influenza virus vaccine: Review of published studies. Rev Infect Dis 1985, 7: 613-8.
69. Versluis, D.J., Beyer, W.E.P., Masurel, N., Weimar, W. Influenza vaccination in dialysis and transplant patients. Antiviral Res 1985, (Suppl.) I: 289-92.
70. Nelson, K.E., Clements, J.L., Miotti, P., Cohn, S., Polk, B.F. The influence of human immunodeficiency virus (HIV) infection on antibody responses to influenza vaccines. Ann Int Med 1988, 109: 383-8.
71. Clements, M.L., Murphy, B.R. Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine. J Clin Microbiol 1986, 23: 66-72.
72. Hocart, M.J., Mackenzie, J.S., Stewart, G.A. Serum IgG subclass responses of humans to inactivated and live influenza A vaccines compared to natural infections with influenza A. J Med Virol 1990, 30: 92-6.
73. Powers, D.C. Effect of age on serum immunoglobulin G subclass antibody responses to inactivated influenza virus vaccine. J Med Virol 1994, 43: 57-61.
74. Remarque, E.J., van Beek, W.C.A., Ligthart, G.J. et al. Improvement of the immunoglobulin subclass response to influenza vaccine in elderly nursing-home residents by the use of high-dose vaccines. Vaccine 1993, 11: 649-54.
75. Dolin, R., Murphy, B.R., Caplan, E.A. Lymphocyte blastogenic responses to influenza virus antigens after influenza infection and vaccination in humans. Infect Immunol 1978, 19: 867-74.
76. Chow, T.C., Beutner, K.R., Ogra, P.L. Cell-mediated immune responses to the hemagglutinin and neuraminidase antigens of influenza A virus after immunization in humans. Infect Immunol 1979, 25: 103-9.
77. Degelau, J.J., O'Leary, J.J., Hallgren, H.M. Relationship of memory and naive T cell subsets to diminished influenza vaccination response in nursing home elderly. Aging Immunol Infect Dis 1994, 5: 27-41.
78. Hsia, J., Tang, T., Parrott, M., Rogalla, K. Augmentation of the immune response to influenza vaccine by acetylsalicylic acid: A clinical trial in a geriatric population. Meth Find Exp Clin Pharmacol 1994, 16: 677-83.
79. McElhaney, J.E., Meneilly, G.S., Beattie, B.L. et al. The effect of influenza vaccination on IL2 production in healthy elderly: Implications for current vaccination practices. J Gerontol 1992, 47: M3-8.
80. Ennis, F.A., Rook, A.H., Hua, Q.Y. et al. HLA-restricted virus-specific T-lymphocyte responses to live and inactivated influenza vaccines. Lancet 1981, II:887-91.
81. McMichael, A.J., Gotch, F., Cullen, P., Askonas, B.A., Webster, W.G. The human cytotoxic T cell response to influenza A vaccination. Clin Exp Immunol 1981, 43: 276-84.
82. Barker, W.H., Mullooly, J.P. Influenza vaccination of elderly persons. Reduction in pneumonia and influenza hospitalizations and deaths. JAMA 1980, 244: 2547-9.
83. Eickhoff, T.C., Meiklejohn, G. Protection against Hong Kong influenza by adjuvant vaccine containing A2/Ann Arbor/67. Bull WHO 1969, 41: 562-3.
84. Edwards, K.M., Dupont, W.D., Westrich, M.K., Plummer, W.D. Jr., Palmer, S.P., Wright, P.F. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. J Infect Dis 1994, 169: 68-76.
85. Nichol, K.L., Lind., A., Margolis, K.L. et al. The effectiveness of vaccination against influenza in healthy, working adults. New Engl J Med 1995, 333: 889-93.
86. Strassburg, M.A., Greenland, S., Sorvillo, F.J., Lieb, L.E., Habel, L.A. Influenza in the elderly: Report of an outbreak and a review of vaccine effectiveness reports. Vaccine 1986, 4: 38-44.
87. Gross, P.A., Hermogenes, A.W., Sacks, H.S., Lau, J., Levandowski, R.A. The efficacy of influenza vaccine in elderly persons. Ann Intern Med 1995, 123: 518-27.
88. Foster, D.A., Talsma, A., Furumoto-Dawson. A. et al. Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly. Amer J Epidemiol 1992, 136: 296-307.
89. Barker, W., Raubertas, R., Menegus, M., O'B-rien, D., Freundlich, C., Betts, R. Case-control study of influenza vaccine effectiveness in preventing pneumonia hospitalization among older persons, Monroe County, New York. 1989-1992. In: Options for the Control of influenza II. Hannoun, C., Kendal, A.P., Klenk, H.D., Ruben, F.L. (Eds.). Excerpta Medica: New York 1993, 143-51.
90. Govaert, T.M., Thijs, C.T., Masurel, N., Sprenger. M.J., Dinant, G.J., Knottnerus, J.A. The efficacy of influenza vaccination in elderly individuals. A randomized, double-blind placebo-controlled trial. JAMA 1994, 272: 1661-5.
91. Nichol, K.L., Margolis, K.L., Wuorenma, J., Von Sternberg. T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. New Engl J Med 1994, 331: 778-84.
92. Centers of Disease Control and Prevention. Final results: Medical influenza vaccine demonstration-selected states, 1988-1992. Morbid Mortal Wkly Rep 1993, 42: 601-4.
93. Hoskins, T.W., Davies, J.R., Smith, A.J., Miller, C.L., Allchin, A. Assessment of inactivated influenza A vaccine after three outbreaks of influenza A at Christ's hospital. Lancet 1979, I: 33-5.
94. Powers, R.D., Hayden, F.G., Samuelson, J., Gwaltney, J.M. Immune response of adults to sequential influenza vaccination. J Med Virol 1984, 14: 169-75.
95. Ahmed, A.H., Nicholson, K.G., Nguyen-Van-Tam, J.S. Reduction in mortality associated with influenza vaccine during 1989-90 epidemic. Lancet 1995, 346: 591-5.
96. Keitel, W.A., Cate, T.R., Couch, R.B. Efficacy of sequential annual vaccination with inactivated influenza virus vaccine. Amer J Epidemiol 1988, 127: 353-64.
97. Morio, S., Okamoto, N., Kawamoto, A., Suyama, A., Okamoto, M., Nakayama, H. Three year follow up study of national influenza vaccination practices in Japan. J Epidemiol Commun Health 1994, 48: 46-51.
98. Nichol, K.L., Korn, J.E., Margolis, K.L., Poland, G.A., Petzel, R.A., Lefgren, R.P. Achieving the national health objective for influenza immunization: Success of an institution-wide vaccination program. Amer J Med 1990, 89: 156-60.
99. Kouides, R.W., Lewis, B., Bennett, N.M. et al. A performance-based incentive program for influenza immunization in the elderly. Amer J Prevent Med 1993, 9: 250-5.
100. Bennett, N.M., Lewis, B., Doniger, A.S. et al. A coordinated, community-wide program in Monroe County, New York, to increase influenza immunization rates in the elderly. Arch Int Med 1994, 154: 1741-5.
101. Karuza, J., Calkins, E., Feather, J., Hershey, C.O., Katz, L., Majeroni, B. Enhancing physician adoption of practice guidelines. Dissemination of influenza vaccination guideline using a small-group consensus process. Arch Int Med 1995, 155: 625-32.
102. Patriarca, P.A. Weber, J.A., Parker, R.A. et al. Risk factors for outbreaks of influenza in nursing homes: A case-control study. Amer J Epidemiol 1986, 124: 114-9.